CD274 and neoplasm: This nano drug can target the mitochondria of tumor cells and activate the AMPK pathway by inhibiting mitochondrial oxidative phosphorylation (OXPHOS), thus down-regulating PDL1 expression to achieve the potent synergistic antitumor effect.